LI
ISEE

Leap Investments’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Leap Investments’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-18,400
Closed -$63K – 613
2020
Q1 		$63K Buy
+18,400
New +$108K 0.09% 316

Other funds holding ISEE

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Leap Investments's ISEE Position: Q2 2020 in Review

Leap Investments sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2020, closing a stake of 18,400 shares — an estimated $63K sold.

Leap Investments first reported a position in ISEE in Q1 2020 and held it in 1 quarter. The position peaked at $63K in Q1 2020. 119 funds tracked by Wall St. Rank hold ISEE as of Q2 2020.

  • Leap Investments reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Leap Investments sold 18,400 IVERIC bio, Inc. Common Stock shares in Q2 2020, an estimated $63K.
  • Leap Investments first reported a position in IVERIC bio, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
  • Leap Investments's IVERIC bio, Inc. Common Stock position peaked at $63K in Q1 2020.
  • 119 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.